{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:45:32Z","timestamp":1785876332119,"version":"3.56.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002975","name":"Dainippon Sumitomo Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013587","name":"Alaska State Council on the Arts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jpet.2026.104949","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:10:24Z","timestamp":1779289824000},"page":"104949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["DSP-2342, a novel 5-hydroxytryptamine 2A\/7 receptor antagonist, has therapeutic potential for behavioral and psychological symptoms of dementia"],"prefix":"10.1016","volume":"393","author":[{"given":"Hikari","family":"Hatakama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohtaroh","family":"Sugao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momoe","family":"Kassai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyomi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6236-5302","authenticated-orcid":false,"given":"Misaki","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6452-0814","authenticated-orcid":false,"given":"Itaru","family":"Natsutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jpet.2026.104949_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11920-019-1049-5","article-title":"Management of behavioral and psychological symptoms of dementia","volume":"21","author":"Bessey","year":"2019","journal-title":"Curr Psychiatry Rep"},{"issue":"5 Suppl 6","key":"10.1016\/j.jpet.2026.104949_bib2","first-page":"S10","article-title":"The neuropsychiatric inventory: assessing psychopathology in dementia patients","volume":"48","author":"Cummings","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jpet.2026.104949_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fneur.2012.00073","article-title":"Behavioral and psychological symptoms of dementia","volume":"3","author":"Cerejeira","year":"2012","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.jpet.2026.104949_bib4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1176\/appi.ajp.157.5.708","article-title":"Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging","volume":"157","author":"Lyketsos","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.jpet.2026.104949_bib5","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3233\/JAD-200516","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative. The relationship between anxiety and incident agitation in Alzheimer\u2019s disease","volume":"78","author":"Liu","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"10.1016\/j.jpet.2026.104949_bib6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1176\/appi.ajp.2011.08121844","article-title":"Cognitive effects of atypical antipsychotic medications in patients with Alzheimer\u2019s disease: outcomes from CATIE-AD","volume":"168","author":"Vigen","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpet.2026.104949_bib7","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jamainternmed.2014.6930","article-title":"Falls and fractures with atypical antipsychotic medication use: a population-based cohort study","volume":"175","author":"Fraser","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"10","key":"10.1016\/j.jpet.2026.104949_bib8","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s40263-025-01200-9","article-title":"Safety and tolerability of brexpiprazole in participants with agitation associated with dementia due to Alzheimer\u2019s disease: pooled analysis of three randomized trials and an extension trial","volume":"39","author":"Shah","year":"2025","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpet.2026.104949_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2016.11.065","article-title":"5-HT7 receptor-mediated fear conditioning and possible involvement of extracellular signal-regulated kinase","volume":"638","author":"Takeda","year":"2017","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.jpet.2026.104949_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/jpet.110.167346","article-title":"Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity","volume":"334","author":"Ishibashi","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.jpet.2026.104949_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.119.260281","article-title":"SEP-363856, a novel psychotropic agent with a unique, non-D2 receptor mechanism of action","volume":"371","author":"Dedic","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"10.1016\/j.jpet.2026.104949_bib12","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s00213-024-06629-2","article-title":"DSP-6745, a novel 5-hydroxytryptamine modulator with rapid antidepressant, anxiolytic, antipsychotic and procognitive effects","volume":"241","author":"Kitaichi","year":"2024","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpet.2026.104949_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fnins.2011.00103","article-title":"Rapid, computer vision-enabled murine screening system identifies neuropharmacological potential of two new mechanisms","volume":"5","author":"Roberds","year":"2011","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jpet.2026.104949_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2014.11.047","article-title":"High-throughput analysis of behavior for drug discovery","volume":"750","author":"Alexandrov","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2026.104949_bib15","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1039\/C6MD00128A","article-title":"In vivo phenotypic drug discovery: applying a behavioral assay to the discovery and optimization of novel antipsychotic agents","volume":"7","author":"Shao","year":"2016","journal-title":"MedChemComm"},{"issue":"7","key":"10.1016\/j.jpet.2026.104949_bib16","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.cell.2016.05.007","article-title":"Mapping of brain activity by automated volume analysis of immediate early genes","volume":"165","author":"Renier","year":"2016","journal-title":"Cell"},{"issue":"4811","key":"10.1016\/j.jpet.2026.104949_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1126\/science.3037702","article-title":"Mapping patterns of c-fos expression in the central nervous system after seizure","volume":"237","author":"Morgan","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.jpet.2026.104949_bib18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nmeth.2477","article-title":"Mapping brain circuitry with a light microscope","volume":"10","author":"Osten","year":"2013","journal-title":"Nat Methods"},{"key":"10.1016\/j.jpet.2026.104949_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.celrep.2014.12.014","article-title":"Mapping social behavior-induced brain activation at cellular resolution in the mouse","volume":"10","author":"Kim","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.jpet.2026.104949_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fncir.2016.00003","article-title":"Whole-brain mapping of neuronal activity in the learned helplessness model of depression","volume":"10","author":"Kim","year":"2016","journal-title":"Front Neural Circuits"},{"issue":"4","key":"10.1016\/j.jpet.2026.104949_bib21","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.cell.2020.04.007","article-title":"The Allen Mouse Brain Common Coordinate Framework: a 3D reference atlas","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jpet.2026.104949_bib22","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.npp.1300678","article-title":"Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists","volume":"30","author":"Chartoff","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.jpet.2026.104949_bib64","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrd4075","article-title":"50 years of hurdles and hope in anxiolytic drug discovery","volume":"12","author":"Griebel","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.jpet.2026.104949_bib23","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41593-018-0126-0","article-title":"A hypothalamic circuit for the circadian control of aggression","volume":"21","author":"Todd","year":"2018","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jpet.2026.104949_bib24","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1038\/s41467-022-31728-z","article-title":"Lateral habenula glutamatergic neurons projecting to the dorsal raphe nucleus promote aggressive arousal in mice","volume":"13","author":"Takahashi","year":"2022","journal-title":"Nat Commun"},{"issue":"8054","key":"10.1016\/j.jpet.2026.104949_bib25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-024-08459-w","article-title":"Experience-dependent dopamine modulation of male aggression","volume":"639","author":"Dai","year":"2025","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jpet.2026.104949_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111577","article-title":"Hyper-excitability of corticothalamic PT neurons in mPFC promotes irritability in the mouse model of Alzheimer\u2019s disease","volume":"41","author":"Zhang","year":"2022","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.jpet.2026.104949_bib27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/npr2.12461","article-title":"Brexpiprazole: a new option in treating agitation in Alzheimer\u2019s dementia-Insights from transgenic mouse models","volume":"44","author":"Amada","year":"2024","journal-title":"Neuropsychopharmacol Rep"},{"issue":"11","key":"10.1016\/j.jpet.2026.104949_bib28","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.euroneuro.2013.08.003","article-title":"Effect of lurasidone on neurocognitive performance in patients with schizophrenia: a short-term placebo- and active-controlled study followed by a 6-month double-blind extension","volume":"23","author":"Harvey","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jpet.2026.104949_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbr.2013.02.019","article-title":"Effects of lurasidone on executive function in common marmosets","volume":"246","author":"Murai","year":"2013","journal-title":"Behav Brain Res"},{"issue":"8","key":"10.1016\/j.jpet.2026.104949_bib30","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/npp.2015.52","article-title":"A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder","volume":"40","author":"Mahableshwarkar","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpet.2026.104949_bib31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.neuropharm.2014.10.015","article-title":"Involvement of 5-HT7 receptors in vortioxetine\u2019s modulation of circadian rhythms and episodic memory in rodents","volume":"89","author":"Westrich","year":"2015","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.jpet.2026.104949_bib32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S2215-0366(17)30046-9","article-title":"Lurasidone versus treatment as usual for cognitive impairment in euthymic patients with bipolar I disorder: a randomized, open-label, pilot study","volume":"4","author":"Yatham","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"10.1016\/j.jpet.2026.104949_bib33","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1007\/s00213-018-4972-y","article-title":"5-HT1A parital agonism and 5-HT7 antagonism restore episodic memory in subchronic phencyclidine-treated mice: role of brain glutamate, dopamine, acetylcholine and GABA","volume":"235","author":"Huang","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"issue":"4772","key":"10.1016\/j.jpet.2026.104949_bib34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.3749894","article-title":"Stimulation of neuronal acetylcholine receptors induces rapid gene transcription","volume":"234","author":"Greenberg","year":"1986","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jpet.2026.104949_bib35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12021-020-09490-8","article-title":"An optimized mouse brain atlas for automated mapping and quantification of neuronal activity using iDISCO+ and light sheet fluorescence microscopy","volume":"19","author":"Perens","year":"2021","journal-title":"Neuroinformatics"},{"issue":"5","key":"10.1016\/j.jpet.2026.104949_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwae109","article-title":"NEATmap: a high-efficiency deep learning approach for whole mouse brain neuronal activity trace mapping","volume":"11","author":"Zheng","year":"2024","journal-title":"Natl Sci Rev"},{"issue":"1","key":"10.1016\/j.jpet.2026.104949_bib37","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/s41467-025-56850-6","article-title":"Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression","volume":"16","author":"Aboharb","year":"2025","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.jpet.2026.104949_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.mp.4000336","article-title":"Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors","volume":"3","author":"Seeman","year":"1998","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jpet.2026.104949_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11062-019-09796-7","article-title":"Involvement of serotonin 5-HT7 receptors in learning and memory in mice","volume":"51","author":"Shahidi","year":"2019","journal-title":"Neurophysiology"},{"key":"10.1016\/j.jpet.2026.104949_bib40","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/jpet.107.119404","article-title":"Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents","volume":"321","author":"Bonaventure","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.jpet.2026.104949_bib41","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrn3945","article-title":"Neuronal circuits for fear and anxiety","volume":"16","author":"Tovote","year":"2015","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104949_bib42","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1038\/s41467-018-05090-y","article-title":"Anterior cingulate cortex and its input to the basolateral amygdala control innate fear response","volume":"9","author":"Jhang","year":"2018","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.jpet.2026.104949_bib43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41583-019-0122-8","article-title":"Affective valence in the brain: modules or modes?","volume":"20","author":"Berridge","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jpet.2026.104949_bib44","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67007","article-title":"The anterior cingulate cortex and its role in controlling contextual fear memory to predatory threats","volume":"11","author":"de Lima","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.jpet.2026.104949_bib45","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1152\/jn.1957.20.6.588","article-title":"Effects of cingulectomy on social behavior in monkeys","volume":"20","author":"Mirsky","year":"1957","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.jpet.2026.104949_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147440","article-title":"GABA-A receptor signaling in the anterior cingulate cortex modulates aggression and anxiety-related behaviors in socially isolated mice","volume":"1762","author":"Chaibi","year":"2021","journal-title":"Brain Res"},{"key":"10.1016\/j.jpet.2026.104949_bib47","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.cub.2021.03.062","article-title":"A central role for anterior cingulate cortex in the control of pathological aggression","volume":"31","author":"van Heukelum","year":"2021","journal-title":"Curr Biol"},{"issue":"5479","key":"10.1016\/j.jpet.2026.104949_bib48","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1126\/science.289.5479.591","article-title":"Dysfunction in the neural circuitry of emotion regulation\u2013a possible prelude to violence","volume":"289","author":"Davidson","year":"2000","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jpet.2026.104949_bib49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/bne0000552","article-title":"The role of the anterior cingulate cortex in aggression and impulsivity","volume":"137","author":"Chaibi","year":"2023","journal-title":"Behav Neurosci"},{"issue":"2","key":"10.1016\/j.jpet.2026.104949_bib50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbr.2004.04.026","article-title":"Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian\/instrumental learning task","volume":"155","author":"Meneses","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.jpet.2026.104949_bib51","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbr.2007.12.020","article-title":"Effect of 5-HT(7) antagonist SB-269970 in the modulation of working and reference memory in the rat","volume":"195","author":"Gasbarri","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.jpet.2026.104949_bib52","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1124\/jpet.109.156349","article-title":"Attenuation of phencyclidine-induced object recognition deficits by the combination of atypical antipsychotic drugs and pimavanserin (ACP 103), a 5-hydroxytryptamine(2A) receptor inverse agonist","volume":"332","author":"Snigdha","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.jpet.2026.104949_bib53","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/jnc.15260","article-title":"Pimavanserin, a 5HT2A receptor inverse agonist, rapidly suppresses A\u03b2 production and related pathology in a mouse model of Alzheimer\u2019s disease","volume":"156","author":"Yuede","year":"2021","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.jpet.2026.104949_bib54","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1017\/S1092852924000427","article-title":"An overview of the pathophysiology of agitation in Alzheimer\u2019s dementia with a focus on neurotransmitters and circuits","volume":"29","author":"Cummings","year":"2024","journal-title":"CNS Spectr"},{"issue":"5","key":"10.1016\/j.jpet.2026.104949_bib55","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s11011-017-0023-3","article-title":"Role of dopamine projections from ventral tegmental area to nucleus accumbens and medial prefrontal cortex in reinforcement behaviors assessed using optogenetic manipulation","volume":"32","author":"Han","year":"2017","journal-title":"Metab Brain Dis"},{"issue":"37","key":"10.1016\/j.jpet.2026.104949_bib56","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1670-24.2025","article-title":"Ventral tegmental area dopamine neural activity switches simultaneously with rule representations in the medial prefrontal cortex and hippocampus","volume":"45","author":"Ding","year":"2025","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpet.2026.104949_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nlm.2019.02.009","article-title":"DREADD-mediated modulation of locus coeruleus inputs to mPFC improves strategy set-shifting","volume":"161","author":"Cope","year":"2019","journal-title":"Neurobiol Learn Mem"},{"issue":"1","key":"10.1016\/j.jpet.2026.104949_bib58","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s42003-022-04051-y","article-title":"Noradrenergic consolidation of social recognition memory is mediated by \u03b2-arrestin-biased signaling in the mouse prefrontal cortex","volume":"5","author":"Cheng","year":"2022","journal-title":"Commun Biol"},{"issue":"22","key":"10.1016\/j.jpet.2026.104949_bib59","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1523\/JNEUROSCI.0552-08.2008","article-title":"Noradrenergic innervation of the dorsal medial prefrontal cortex modulates hypothalamo-pituitary-adrenal responses to acute emotional stress","volume":"28","author":"Radley","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpet.2026.104949_bib60","article-title":"Enhanced medial prefrontal cortex and hippocampal activity improves memory generalization in APP\/PS1 mice: a multimodal animal MRI study","volume":"16","author":"Liu","year":"2022","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104949_bib61","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41467-022-28493-4","article-title":"Acetylcholine deficiency disrupts extratelencephalic projection neurons in the prefrontal cortex in a mouse model of Alzheimer\u2019s disease","volume":"13","author":"Sun","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.jpet.2026.104949_bib62","first-page":"464","article-title":"Influence of serotonin 5-HT(7) receptor blockade on the behavioral and neurochemical effects of imipramine in rats","volume":"60","author":"Weso\u0142owska","year":"2008","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.jpet.2026.104949_bib63","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fncel.2015.00324","article-title":"5-HT7 receptor modulates GABAergic transmission in the rat dorsal raphe nucleus and controls cortical release of serotonin","volume":"9","author":"Kusek","year":"2015","journal-title":"Front Cell Neurosci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:59:00Z","timestamp":1785873540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526011481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0022356526011481"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104949","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DSP-2342, a novel 5-hydroxytryptamine 2A\/7 receptor antagonist, has therapeutic potential for behavioral and psychological symptoms of dementia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"104949"}}